SRPT logo

Sarepta Therapeutics (SRPT) Non current assets

Annual non current assets:

$889.71M+$204.47M(+29.84%)
December 31, 2024

Summary

  • As of today (May 29, 2025), SRPT annual long term assets is $889.71 million, with the most recent change of +$204.47 million (+29.84%) on December 31, 2024.
  • During the last 3 years, SRPT annual non current assets has risen by +$345.83 million (+63.59%).
  • SRPT annual non current assets is now at all-time high.

Performance

SRPT Non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

quarterly non current assets:

$1.03B+$143.14M(+16.09%)
March 1, 2025

Summary

  • As of today (May 29, 2025), SRPT quarterly long term assets is $1.03 billion, with the most recent change of +$143.14 million (+16.09%) on March 1, 2025.
  • Over the past year, SRPT quarterly non current assets has increased by +$273.33 million (+35.99%).
  • SRPT quarterly non current assets is now at all-time high.

Performance

SRPT quarterly non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTbalance sheet metrics

Non current assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

SRPT Non current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+29.8%+36.0%
3 y3 years+63.6%+96.7%
5 y5 years+151.4%+158.2%

SRPT Non current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+63.6%at high+96.7%
5 y5-yearat high+151.4%at high+158.2%
alltimeall timeat high>+9999.0%at high>+9999.0%

SRPT Non current assets History

DateAnnualQuarterly
Mar 2025
-
$1.03B(+16.1%)
Dec 2024
$3.07B(+19.2%)
$889.71M(-2.7%)
Sep 2024
-
$914.57M(+23.5%)
Jun 2024
-
$740.62M(-2.5%)
Mar 2024
-
$759.52M(+10.8%)
Dec 2023
$2.58B(+0.8%)
$685.25M(+4.0%)
Sep 2023
-
$658.86M(+0.9%)
Jun 2023
-
$653.28M(+14.3%)
Mar 2023
-
$571.41M(+0.2%)
Dec 2022
$2.56B(-1.8%)
$570.50M(+7.6%)
Sep 2022
-
$530.22M(+0.5%)
Jun 2022
-
$527.55M(+0.4%)
Mar 2022
-
$525.21M(-3.4%)
Dec 2021
$2.60B(+4.8%)
$543.88M(+14.0%)
Sep 2021
-
$476.91M(-3.4%)
Jun 2021
-
$493.86M(-0.0%)
Mar 2021
-
$493.88M(-1.1%)
Dec 2020
$2.49B(+69.2%)
$499.52M(+9.1%)
Sep 2020
-
$457.99M(+8.1%)
Jun 2020
-
$423.62M(+5.9%)
Mar 2020
-
$400.04M(+13.0%)
Dec 2019
$1.47B(+3.0%)
$353.91M(+4.0%)
Sep 2019
-
$340.17M(+6.2%)
Jun 2019
-
$320.33M(+9.5%)
Mar 2019
-
$292.47M(+35.5%)
Dec 2018
$1.43B(+16.1%)
$215.89M(+26.4%)
Sep 2018
-
$170.83M(+58.3%)
Jun 2018
-
$107.92M(+33.5%)
Mar 2018
-
$80.87M(+1.9%)
Dec 2017
$1.23B(+229.0%)
$79.32M(+22.6%)
Sep 2017
-
$64.67M(+8.6%)
Jun 2017
-
$59.55M(+9.8%)
Mar 2017
-
$54.23M(+7.1%)
Dec 2016
$373.48M(+66.3%)
$50.63M(-3.7%)
Sep 2016
-
$52.57M(+3.3%)
Jun 2016
-
$50.87M(-3.4%)
Mar 2016
-
$52.64M(+6.9%)
Dec 2015
$224.54M(-9.4%)
$49.24M(-21.4%)
Sep 2015
-
$62.64M(+27.0%)
Jun 2015
-
$49.32M(-0.7%)
Mar 2015
-
$49.66M(+5.1%)
Dec 2014
$247.80M(-8.5%)
$47.24M(-4.1%)
Sep 2014
-
$49.24M(+50.9%)
Jun 2014
-
$32.64M(+25.4%)
Mar 2014
-
$26.02M(+25.3%)
Dec 2013
$270.81M(+39.7%)
$20.76M(+47.7%)
Sep 2013
-
$14.06M(+31.0%)
Jun 2013
-
$10.73M(-35.9%)
Mar 2013
-
$16.75M(+51.1%)
Dec 2012
$193.91M(+329.2%)
$11.09M(+1.5%)
Sep 2012
-
$10.92M(+23.2%)
Jun 2012
-
$8.87M(-1.6%)
Mar 2012
-
$9.02M(-1.8%)
Dec 2011
$45.18M(+19.4%)
$9.18M(+0.5%)
Sep 2011
-
$9.14M(+2.6%)
Jun 2011
-
$8.91M(+4.4%)
Mar 2011
-
$8.54M(+4.9%)
DateAnnualQuarterly
Dec 2010
$37.84M(-26.3%)
$8.14M(-4.8%)
Sep 2010
-
$8.55M(-2.2%)
Jun 2010
-
$8.73M(+0.7%)
Mar 2010
-
$8.68M(-0.5%)
Dec 2009
$51.31M(+201.0%)
$8.72M(+6.6%)
Sep 2009
-
$8.18M(-1.4%)
Jun 2009
-
$8.29M(+0.6%)
Mar 2009
-
$8.24M(-3.0%)
Dec 2008
$17.04M(-40.6%)
$8.49M(-13.8%)
Sep 2008
-
$9.86M(-1.8%)
Jun 2008
-
$10.03M(-0.8%)
Mar 2008
-
$10.12M(+1.9%)
Dec 2007
$28.71M(-15.4%)
$9.93M(-1.8%)
Sep 2007
-
$10.11M(+1.2%)
Jun 2007
-
$9.99M(+42.8%)
Mar 2007
-
$7.00M(+1.1%)
Dec 2006
$33.94M(-30.2%)
$6.92M(-4.5%)
Sep 2006
-
$7.25M(-0.4%)
Jun 2006
-
$7.28M(-0.9%)
Mar 2006
-
$7.35M(-5.2%)
Dec 2005
$48.65M(+140.9%)
$7.75M(-3.3%)
Sep 2005
-
$8.02M(-1.2%)
Jun 2005
-
$8.11M(-1.4%)
Mar 2005
-
$8.22M(-1.2%)
Dec 2004
$20.20M(-47.4%)
$8.32M(-2.9%)
Sep 2004
-
$8.57M(+0.9%)
Jun 2004
-
$8.49M(-1.7%)
Mar 2004
-
$8.64M(-1.3%)
Dec 2003
$38.39M(+88.2%)
$8.75M(-0.5%)
Sep 2003
-
$8.80M(-0.5%)
Jun 2003
-
$8.85M(+1.1%)
Mar 2003
-
$8.75M(+6.7%)
Dec 2002
$20.40M(-25.8%)
$8.20M(+6.3%)
Sep 2002
-
$7.71M(+6.2%)
Jun 2002
-
$7.27M(+3.3%)
Mar 2002
-
$7.04M(+11.6%)
Dec 2001
$27.51M(-17.0%)
$6.30M(+45.9%)
Sep 2001
-
$4.32M(+23.0%)
Jun 2001
-
$3.51M(+17.9%)
Mar 2001
-
$2.98M(+52.2%)
Dec 2000
$33.13M(+183.2%)
$1.96M(+12.1%)
Sep 2000
-
$1.75M(-4.6%)
Jun 2000
-
$1.83M(+34.3%)
Mar 2000
-
$1.36M(+13.5%)
Dec 1999
$11.70M(+30.0%)
$1.20M(-7.7%)
Sep 1999
-
$1.30M(0.0%)
Jun 1999
-
$1.30M(0.0%)
Mar 1999
-
$1.30M(+8.3%)
Dec 1998
$9.00M(-49.2%)
$1.20M(+9.1%)
Sep 1998
-
$1.10M(-15.4%)
Jun 1998
-
$1.30M(+8.3%)
Mar 1998
-
$1.20M(+9.1%)
Dec 1997
$17.70M(+490.0%)
$1.10M(+22.2%)
Sep 1997
-
$900.00K(0.0%)
Jun 1997
-
$900.00K(-35.7%)
Mar 1997
-
$1.40M
Dec 1996
$3.00M
-

FAQ

  • What is Sarepta Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Sarepta Therapeutics?
  • What is Sarepta Therapeutics annual non current assets year-on-year change?
  • What is Sarepta Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Sarepta Therapeutics?
  • What is Sarepta Therapeutics quarterly non current assets year-on-year change?

What is Sarepta Therapeutics annual long term assets?

The current annual non current assets of SRPT is $889.71M

What is the all time high annual non current assets for Sarepta Therapeutics?

Sarepta Therapeutics all-time high annual long term assets is $889.71M

What is Sarepta Therapeutics annual non current assets year-on-year change?

Over the past year, SRPT annual long term assets has changed by +$204.47M (+29.84%)

What is Sarepta Therapeutics quarterly long term assets?

The current quarterly non current assets of SRPT is $1.03B

What is the all time high quarterly non current assets for Sarepta Therapeutics?

Sarepta Therapeutics all-time high quarterly long term assets is $1.03B

What is Sarepta Therapeutics quarterly non current assets year-on-year change?

Over the past year, SRPT quarterly long term assets has changed by +$273.33M (+35.99%)
On this page